Assertion: technetium | /r/HasProperty | tc 99m depreotide injection
Facets:
Source sentences:
text: The NeoTect® (technetium tc 99m depreotide injection)
text: The recommended dose of technetium Tc 99m tilmanocept is 18.5 MBq (0.5 mCi) as a radioactivity dose and 50 mcg as a mass dose, administered at least 15 minutes prior to initiating intraoperative lymphatic mapping.
text: The NeoTect® (technetium tc 99m depreotide injection) images were scored negative if abnormal localization was not found.
text: The interpretation of NeoTect® (technetium tc 99m depreotide injection) images was negative in 29% (54/184) of patients when the biopsy reports were positive for adenocarcinoma, squamous cell, carcinoid or non-small cell cancer (i.e., false-negative NeoTect® (technetium
text: Also, the interpretation of NeoTect® (technetium tc 99m depreotide injection) was positive in 17% (7/42) of patients when the biopsy results were consistent with acute or chronic inflammation, infectious processes including abscess and pneumonia, hamartoma, fibrosis, or caseating or non-caseating granulomas (i.e., false-positive NeoTect® (technetium tc 99m depreotide injection)
text: The clinical relevance of other combinations of image results (e.g., CT and NeoTect® (technetium tc 99m depreotide injection) both negative, CT negative and NeoTect® (technetium tc 99m depreotide injection) scan positive; or CT positive and NeoTect® (technetium
text: The technetium Tc 99m is well retained in the blood pool with an estimated biological half-life of approximately 29 hours.